Title : CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2.

Pub. Date : 2017 Nov

PMID : 28893623






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2. abiraterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens
2 Abiraterone is an inhibitor of CYP17A1 which is used for the treatment of castration resistant prostate cancer. abiraterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens
3 A loss of CYP21A2 activity in combination with reduction of CYP17A1 activities by abiraterone could result in lower cortisol levels and may require monitoring for any potential adverse effects. abiraterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens